BioWorld Asia

Oct. 17, 2007

Look At Health Care Through Different Lens, P&G Advises

LONDON - Proctor and Gamble (P&G) is applying its expertise as a consumer products giant to get a patient's eye view of disease and use the insights to inform development programs with biotech partners. (BioWorld International) Read More

EuropaBio Takes Its Message To The Top

Genetic Screening For Bowel Cancer Risk Closer To Reality

Victoria Sets A Lofty Goal For Advancing Its Biotech

Cellectis and Servier Enter Cell Engineering Alliance

Other News To Note

Nobel Laureate's Interests Are As Broad As His Technology

Deals To M&As: The Culture Of False-Flagging, Shape-Shifting

Orexo Acquires A Pipeline In $133M Deal for Biolipox

Today's news in brief

BioWorld

BioWorld briefs for Feb. 5, 2025.

MicroRNAs in circulating extracellular vesicles as IPF biomarkers

BioWorld Science

MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...

MJFF grant supports Bexorg’s translational biomarker work

BioWorld Science

Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...

REST emerges as biomarker in ALS, knockdown improves ALS symptoms

BioWorld Science

About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...

Illustration of liver being targets with cross-hairs

Study identifies CAND1 as therapeutic target in hepatoblastoma

BioWorld Science

Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...